From: The contribution of the meningeal immune interface to neuroinflammation in traumatic brain injury
Immune signature/trigger | Time |
---|---|
Fluid biomarkers | |
 IFNγ | ↑ 1–5 days after injury [35, 36], ↑ up to 12 months [37] |
 TNF | ↑ 6 h–2 weeks days [24, 35, 38,39,40,41,42,43,44,45,46,47,48,49,50], ↑ up to 12 months [37] |
 IL-1β | |
 IL-6 | ↑ 6 h–2 weeks [24, 36, 46, 47, 49,50,51,52, 56, 58,59,60,61,62,63,64,65,66,67,68], ↑ up to 6 months [69] |
 IL-10 | |
 IL-8 (CXCL8) | ↑ 2 h–5 days [48, 50, 51, 59, 69, 74], ↑ up to 12 months [37] |
 IL-12p70 | |
 TGFβ | |
 CCL2 | |
 CCL3 | |
 CXCL8 (IL-8) | |
 IL-18 | ↑ up to 10 days [80] |
 sIL-2R | ↑1–21 days [81] |
 IL-17, IL-22 | |
 IL-2 | ↑ 24 h post injury [67] |
 IL-9 | ↑ admission–12 months [37] |
 IL-4 | ↑ within 48 h post injury [59] |
 iNOS | ↑24 h post injury [47] |
 NADPH | ↑24 h post injury [47] |
 COX-2 | ↑24 h post injury [47] |
Tissue | |
 IFNγ | ↑ 17 min–5 days injury [70] |
 TNF | ↑ 17 min–5 days injury [70] |
 IL-1β | ↑ 6 h–5days after injury [70] |
 IL-6 | |
 CCL2 | ↑ 3 h–15 days post-injury [78] |
 CCL3 | ↑ 3 h–15 days post-injury [78] |
 IL-8 (CXCL8) | |
 IL-2 | ↑ 17 min–5 days injury [70] |
 NOX2 | ↑12–24 h post injury [82] |
 NOX4 | ↑12–48 h post injury [82] |